Rizatriptan Benzoate
Product Images NDC 50090-3921
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 50090-3921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Rizatriptan 01)
Figure 1 (Rizatriptan 02)
This is a graph that shows an estimated probability of response for Rizatriptan benzoate tablets. The graph presents different percentages based on the hours post-dose and the dosage. There are different possibilities of response, from 0% to 100%, with a curve showing the highest probability of response around 2 hours post-dose.*
Figure 2 (Rizatriptan 03)
This appears to be a graph or chart representing the estimated probability of remedication or rescue after taking different dosages of Rizatriptan Benzoate Tablets. The x-axis shows hours post-dose and the y-axis shows the estimated probability percentage. The two dosages shown are 5 mg and 10 mg. However, the text is incomplete and not entirely clear, so more information cannot be accurately determined.*
Figure 5 (Rizatriptan 04)
Image (Rizatriptan 05)
Image (Rizatriptan 06)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.